Magnetar Financial’s Aerie Pharmaceuticals AERI Stock Holding History

Magnetar Financial’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-441,584	Closed	-$6.68M	–	1443
2022 Q3	$6.68M	Buy	+441,584	New	+$5.13M	0.09%	250

Magnetar Financial's AERI Position: Q4 2022 in Review

Magnetar Financial sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 441,584 shares — an estimated $6.68M sold.

Magnetar Financial first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $6.68M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Magnetar Financial reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Magnetar Financial sold 441,584 Aerie Pharmaceuticals shares in Q4 2022, an estimated $6.68M.
Magnetar Financial first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Magnetar Financial's Aerie Pharmaceuticals position peaked at $6.68M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Magnetar Financial's 13F filing for Q4 2022, filed 14 Feb 2023.